Literature DB >> 6508274

Biliary elimination of apalcillin in humans.

J M Brogard, J P Arnaud, J F Blickle, J Lavillaureix.   

Abstract

Apalcillin was administered intravenously as a single 1-g dose on day 8 after surgery to 10 cholecystectomized patients with T-tube drainage. A peak of 2,093 +/- standard error of the mean 859 micrograms/ml of bile was attained at 3 h after dosage. Biliary recovery over a 12-h period amounted to 12.2% of the dose. In 20 patients undergoing biliary surgery, apalcillin concentrations 1 h after a 1-g dose were 65.5 +/- 5.0, 3,680 +/- 551, and 2,552 +/- 627 micrograms/ml in serum, choledochal bile, and gallbladder bile, respectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508274      PMCID: PMC176188          DOI: 10.1128/AAC.26.3.428

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Bile drainage after choledochostomy in man, with some observations on biliary fistula.

Authors:  F F RUNDLE; M H CASS; B ROBSON; M MIDDLETON
Journal:  Surgery       Date:  1955-06       Impact factor: 3.982

2.  PC-904, a new semisynthetic penicillin.

Authors:  G P Bodey; S Weaver; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

4.  Biliary elimination of mezlocillin: an experimental and clinical study.

Authors:  J M Brogard; J Kopferschmitt; J P Arnaud; M Dorner; J La Villaureix
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

  4 in total
  3 in total

1.  Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.

Authors:  J M Brogard; F Jehl; H Monteil; M Adloff; J F Blickle; P Levy
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

2.  Biliary excretion of olsalazine sodium in humans.

Authors:  M Ryde; S Gustavsson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jan-Mar       Impact factor: 2.441

3.  Ciprofloxacin biliary disposition in cholecystectomised patients with special references to HPLC and bioassay data.

Authors:  F Jehl; M Adloff; H Monteil; J M Brogard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Apr-Jun       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.